Submitted by admin on September 25, 2018 - 12:05pm
AZ’s Imfinzi provides unprecedented progression-free survival in NSCLC
Express Scripts takes credit for Gilead hep C generics
Novartis cutting 2000 jobs in Switzerland
Arena’s Crohn’s drug meets proof-of-concept test
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*
Today's most popular searches:
For banking news and anonymous forums, be sure to check out cafebanking.com
